Apex Egypt

Apex Egypt, established in 1997, is a prominent pharmaceutical manufacturer based in Egypt, dedicated to producing high-quality generic medications across diverse therapeutic categories. The company's core mission is to bolster national self-sufficiency in essential medicines, adhering strictly to international quality and safety benchmarks, including WHO and GMP regulations. This commitment ensures the efficacy and reliability of its pharmaceutical offerings for healthcare providers and patients.

Demonstrating significant growth and strategic vision, Apex Egypt has expanded its operational footprint into Saudi Arabia, aligning with the nation's Vision 2030 objectives. The company operates with a workforce of 500 - 1,000 employees across its two locations, driving its production and distribution capabilities. Meet Apex Egypt's team to understand the expertise behind their quality assurance and expansion initiatives.

Apex Egypt targets healthcare providers and patients throughout the MENA region, delivering innovative and effective pharmaceutical solutions. With an annual revenue of $249.6M, the company is a key player in the regional healthcare landscape, focused on accessibility and affordability of critical medications. Its strategic expansion into new markets and a robust product portfolio underscore its role in advancing public health across its operational territories, contributing to improved patient outcomes.